-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- This week in PLOS Biology in Work In Progress
- Are meta analyses conducted by professional organizations more trustworthy? in Work In Progress
- Awl be Darned: Metal Arrived in the Southern Levant Long Before Previously Thought in Work In Progress
- 3, 2, 1...Project MERCCURI Blasts Off to the ISS Today!! in Work In Progress
- Learning from the South: influenza immunization in pregnancy in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.